Inventor · disambiguated record
Wendy Chao
Also filed as: CHAO WENDY
11 granted patents·9 pending applications·102 citations·filing 2007–2021
90Inventor score
Top patents by PatentIndex Score
20 records- 0197US8415401B2Oral pharmaceutical dosage formsYUM SU IL·Filed 2008·Granted Apr 9, 2013·64 cites·19 claims
- 0293US9572885B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2014·Granted Feb 21, 2017·8 cites·26 claims
- 0390US9655861B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2015·Granted May 23, 2017·6 cites·16 claims
- 0490US9555113B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2014·Granted Jan 31, 2017·5 cites·19 claims
- 0589US9592204B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2013·Granted Mar 14, 2017·8 cites·17 claims
- 0688US9855333B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2017·Granted Jan 2, 2018·2 cites·25 claims
- 0780US8287523B2Systems and methods for historical display of surgical operating parametersWONG WAYNE S·Filed 2007·Granted Oct 16, 2012·9 cites·8 claims
- 0871US2020101021A1Oral pharmaceutical dosage formsDURECT CORP·Filed 2019·Application pending·0 cites
- 0970US2009298862A1Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic conditionYUM SU IL·Filed 2009·Application pending·0 cites
- 1070US2018236078A1Compositions with a Rheological Modifier to Reduce Dissolution VariabilityDURECT CORP·Filed 2018·Application pending·0 cites
- 1169US2019231702A1Oral Pharmaceutical Dosage FormsDURECT CORP·Filed 2018·Application pending·0 cites
- 1268US10206883B2Oral pharamaceutical dosage formsDURECT CORP·Filed 2017·Granted Feb 19, 2019·0 cites·20 claims
- 1368US9907851B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2016·Granted Mar 6, 2018·0 cites·11 claims
- 1465US10300142B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2017·Granted May 28, 2019·0 cites·20 claims
- 1564US2017319501A1Oral Pharmaceutical Dosage FormsDURECT CORP·Filed 2017·Application pending·0 cites
- 1663US2022175798A1Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, carboxymethyl cellulose and polyoxylglycerideDURECT CORP·Filed 2021·Application pending·0 cites
- 1763US2013317049A1Methods Useful for the Treatment of Pain, Arthritic Conditions or Inflammation Associated with a Chronic ConditionDURECT CORP·Filed 2012·Application pending·0 cites
- 1853US2020222430A1Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, carboxymethyl cellulose and polyoxylglycerideDURECT CORP·Filed 2017·Application pending·0 cites
- 1953US2016038479A1Compositions with Thixotropy and Enhanced Dissolution Reproducibility and StabilityDURECT CORP·Filed 2014·Application pending·0 cites
- 2032US12274794B2Oral dosage form with drug composition, barrier layer and drug layerORIENT PHARMA CO LTD·Filed 2017·Granted Apr 15, 2025·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Wendy Chao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →